By making assessments of a person's cardiac risk more accurate and more convenient, it may be possible to fundamentally change the way cardiac disease is managed by focusing on prevention. Click here to find out more about Abbott’s high sensitive Troponin-I test and the role of diagnostics in cardiac health. *Abbott’s high sensitive Troponin-I test for cardiac risk is the first to receive CE Marking, an indicator that it complies with European health, safety and environmental protection standards for products sold in the European Economic Area. References 1Cardiovascular Diseases Fact Sheet. World Health Organization, May 2017. Web site: http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). 2Sigurdardottir FD et al. Am J Cardiol. 2018;121(8):949-955. https://doi.org/10.1016/j.amjcard.2018.01.004 3Ford I et al. J Am Coll Cardiol. 2016; 68(25) 2719-2728. 4Blankenberg S et al. Eur Heart J. 2016 Aug 7;37(30):2428-37. 5Omland T et al. Clin Chem. 2015 Apr;61(4):646-56. 6Everett et al. Circulation. 2015; 131(21):1851-1860.